Financial Services
Live Price
Offline$18.60
+0.27% today
1Y Change
+4.50%
Window
Jun 23, 2025 → Jun 9, 2026
Coverage: 242 bars · Jun 23, 2025 → Jun 9, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Abrdn Healthcare Opportunities Fund (THQ) is a fund with a market cap of $770.00M and listed on NYSE. The fund last traded around $18.60 and up 4.5% across the available one-year price window (Jun 23, 2025 → Jun 9, 2026). Baseline metrics include a dividend yield of 11.6%. Valuation already assumes a fairly strong business story at price/sales 50.3. Stock Foundry combines THQ price history, analyst forecasts, news, related Financial Services peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
THQ
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
THQ Max Drawdown
-19.10%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for THQ and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$196.5M
+182.5% YoY
FY Net Income
$194.7M
+325.7% YoY
Free Cash Flow
$33.1M
-40.5% YoY
Revenue Growth
-152.8%
EPS Growth
-160.7%
Gross Margin
-66.9%
Net Margin
-751.8%
Income statement
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | -101M | 191M | 81M | 70M | 197M |
| Gross Profit | -114M | 191M | 68M | 56M | 197M |
| Operating Income | -115M | 205M | 14M | -82M | 195M |
| EBITDA | -115M | 205M | 66M | -82M | 195M |
| Net Income | -115M | 190M | 53M | -86M | 195M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 0 | 0 | 538 | 17M | 932 |
| Total Assets | 970M | 1.2B | 1.1B | 1.1B | 1.2B |
| Total Liabilities | 230M | 229M | 230M | 230M | 263M |
| Shareholder Equity | 741M | 944M | 833M | 836M | 977M |
| Total Debt | 225M | 225M | 225M | 225M | 225M |
| Net Debt | 225M | 225M | 225M | 208M | 225M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
33M
-40.5% YoY
Capital Expenditures
0
Free Cash Flow
33M
-40.5% YoY
Key ratios
Gross Margin
-66.9%
Operating Margin
-751.8%
Net Margin
-751.8%
ROE
-14.5%
Debt / Equity
0.30x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.